scPharmaceuticals (SCPH) IPO Opens Fractionally Higher
Get Alerts SCPH Hot Sheet
Join SI Premium – FREE
Today's IPO scPharmaceuticals Inc. (NASDAQ: SCPH) opened for trading at $14.25 after pricing 6,400,000 shares of common stock at a public offering price of $14.00 per share.
In addition, the Company has granted the underwriters a 30-day option to purchase up to 960,000 additional shares of common stock at the initial public offering price, less the underwriting discount.
Jefferies, Leerink Partners and BMO Capital Markets are acting as joint book-running managers for the offering.
scPharmaceuticals is a clinical-stage pharmaceutical company focused on developing and commercializing products that have the potential to transform the way therapy is delivered, advance patient care and reduce healthcare costs. Our proprietary platform is designed to enable the subcutaneous administration of therapies that have previously been limited to intravenous (IV) delivery.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- U-BX Technology (UBXG) IPO Opens At $5, Priced at $5
- Bannix and GBT Partner to Bring Revolutionary Imaging Tech "VisionWave" to Market
- Midday movers: RH, Estee Lauder rise; Tesla falls
Create E-mail Alert Related Categories
IPOsRelated Entities
Jefferies & Co, BMO Capital, IPOSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!